Seneste forsøg

EudraCT Number: 2022-003588-55 Sponsor Protocol Number: 20221102 Start Date: 2024-10-14
Sponsor Name: Isala
Full Title: Evaluating the safety of shortened infusion tiMes for dIfferent oNcological immUnoThErapies; An observational prospective study
Medical condition: Oncology
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: NL (Ongoing)
Trial results: (No results available)
EudraCT Number: 2018-002373-22 Sponsor Protocol Number: hNSCALSII Start Date: 2024-05-31
Sponsor Name: FONDAZIONE CASA SOLLIEVO DELLA SOFFERENZA OPERA DI SAN PIO DA PIETRELCINA OSPEDALE IRCCS
Full Title: Neural Stem Cell Treatment for Amyotrophic Lateral Sclerosis: A multicenter, randomized placebo controlled and biological endpoints clinical Trial
Medical condition: Amyotrophic Lateral Sclerosis (ALS)
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Male, Female
Trial protocol: IT (Trial now transitioned)
Trial results: (No results available)
EudraCT Number: 2020-004231-25 Sponsor Protocol Number: MS201923_0050 Start Date: 2024-05-21
Sponsor Name: Merck Healthcare KGaA
Full Title: A Phase II, open-label, single-arm study of berzosertib (M6620) in combination with topotecan in participants with relapsed platinum-resistant small-cell lung cancer
Medical condition: Relapsed platinum resistant small-cell lung cancer
Disease: Version SOC Term Classification Code Term Level
21.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10041067 Small cell lung cancer PT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: FR (Completed) IT (Completed) ES (Temporarily Halted)
Trial results: (No results available)
EudraCT Number: 2020-004633-21 Sponsor Protocol Number: APHP191047 Start Date: 2024-04-29
Sponsor Name: Assistance Publique -Hopitaux de Paris
Full Title:
Medical condition:
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: FR (Trial now transitioned)
Trial results: (No results available)
EudraCT Number: 2020-003745-11 Sponsor Protocol Number: 1346-0014 Start Date: 2024-03-02
Sponsor Name: Boehringer Ingelheim
Full Title: An open label, single arm, extension trial to examine long-term safety of BI 425809 once daily in patients with schizophrenia who have completed previous BI 425809 Phase III trials.(CONNEX-X)
Medical condition: Schizophrenia
Disease: Version SOC Term Classification Code Term Level
20.0 10037175 - Psychiatric disorders 10039626 Schizophrenia PT
Population Age: Adults Gender: Male, Female
Trial protocol: FR (Trial now transitioned) CZ (Trial now transitioned) ES (Ongoing) SK (Trial now transitioned) HU (Trial now transitioned) NO (Trial now transitioned) DK (Trial now transitioned) LT (Trial now transitioned) IT (Trial now transitioned) GR (Trial now transitioned) BE (Trial now transitioned) SE (Trial now transitioned) NL (Trial now transitioned) FI (Trial now transitioned) HR (Trial now transitioned) AT (Trial now transitioned) BG (Ongoing) PT (Trial now transitioned) RO (Trial now transitioned)
Trial results: (No results available)
EudraCT Number: 2023-000005-12 Sponsor Protocol Number: CRCFC-TEICO.SA.2022 Start Date: 2024-02-21
Sponsor Name: AZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA
Full Title: An open-label study to evaluate the safety and tolerability of inhaled Teicoplanin in the treatment of Staphylococcus aureus (including mrsa) infections in CYSTIC FIBROSIS PATIENTS
Medical condition: cystic fibrosis associated to persistent Staphylococcus aureus (including MRSA) infection
Disease: Version SOC Term Classification Code Term Level
20.0 10010331 - Congenital, familial and genetic disorders 10011762 Cystic fibrosis PT
20.0 100000004862 10075981 Staphylococcus aureus infection LLT
Population Age: Adolescents, Under 18, Adults Gender: Male, Female
Trial protocol: IT (Trial now transitioned)
Trial results: (No results available)
EudraCT Number: 2022-003922-27 Sponsor Protocol Number: PAM-UMCG-002 Start Date: 2024-02-08
Sponsor Name: University Medical Center Groningen (UMCG)
Full Title: Neo-adjuvant Pembrolizumab as alternative to radio(chemo)therapy in MMRd uterine cancer
Medical condition: Primary uterine cancer characterized with dMMR
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Female
Trial protocol: NL (Ongoing)
Trial results: (No results available)
EudraCT Number: 2022-004238-20 Sponsor Protocol Number: CC21000 Start Date: 2024-02-06
Sponsor Name: Vejle Hospital
Full Title: BONG: Breathlessness and alternatives to Opioid treatment in Non-malign Groups of severe lung disease
Medical condition: COPD
Disease: Version SOC Term Classification Code Term Level
21.1 10042613 - Surgical and medical procedures 10075530 Medical cannabis therapy PT
21.1 10038738 - Respiratory, thoracic and mediastinal disorders 10010952 COPD LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DK (Trial now transitioned)
Trial results: (No results available)
EudraCT Number: 2020-004168-24 Sponsor Protocol Number: BETHESDaCD Start Date: 2023-12-29
Sponsor Name: Medical University of Warsaw
Full Title: Evaluation of the efficacy of topical treatment with budesonide in children with Crohn's disease located in the esophagus and/or stomach and/or duodenum - BETHESDa
Medical condition: Crohn's disease
Disease: Version SOC Term Classification Code Term Level
20.0 10017947 - Gastrointestinal disorders 10017947 Gastrointestinal disorders SOC
Population Age: Children, Adolescents, Under 18 Gender: Male, Female
Trial protocol: PL (Ongoing)
Trial results: (No results available)
EudraCT Number: 2022-003573-32 Sponsor Protocol Number: 2022/ABM/01/00027 Start Date: 2023-12-28
Sponsor Name: Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu
Full Title: A randomized, double-blind, placebo-controlled study to evaluate the effect of allopurinol on the risk of cardiovascular events in patients at high and very high cardiovascular risk, including the ...
Medical condition: hyperuricemia, hypertension, ischemic stroke, intracerebral haemorrhage, TIA, heart failure, peripheral arterial disease, atrial fibrillation, diabetes mellitus
Disease: Version SOC Term Classification Code Term Level
20.1 10027433 - Metabolism and nutrition disorders 10020907 Hyperuricemia LLT
20.0 10047065 - Vascular disorders 10020772 Hypertension PT
22.1 10029205 - Nervous system disorders 10061256 Ischaemic stroke PT
21.1 10029205 - Nervous system disorders 10044390 Transient ischaemic attack PT
20.0 10007541 - Cardiac disorders 10019279 Heart failure LLT
20.0 10027433 - Metabolism and nutrition disorders 10012601 Diabetes mellitus PT
27.1 10007541 - Cardiac disorders 10003658 Atrial fibrillation PT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: PL (Ongoing)
Trial results: (No results available)

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner